Visceral Adipose Tissue Cutoffs Associated with Metabolic Risk Factors for Coronary Heart Disease in Women
Overview
Authors
Affiliations
Objective: This study determined whether there is a critical level of visceral adipose tissue (VAT) associated with elevated coronary heart disease (CHD) risk factors in a cohort of women >45 years of age.
Research Design And Methods: Measurements of body composition (dual-energy X-ray absorptiometry), body fat distribution (computed tomography), fasting and 2-h postprandial (75-g) glucose concentrations, and fasting lipoprotein lipid and insulin concentrations were performed in 233 perimenopausal (9%) and postmenopausal women (age 59 +/- 6 years, 79% Caucasian, 16% on hormone replacement therapy).
Results: Women in the lowest VAT quintile (< or =105 cm(2)) had higher concentrations of HDL and HDL(2) cholesterol, lower LDL/HDL cholesterol ratios and triglyceride concentrations, and lower fasting glucose and insulin concentrations than women in the remaining four quintiles (P values <0.05-0.001). Women in the second lowest VAT quintile (106-139 cm(2)) had higher HDL and HDL(2) cholesterol and lower LDL/HDL ratios than women with a VAT > or =163 cm(2) (P < 0.05). Logistic regression analyses showed that women with a VAT of 106-162 cm(2) are 2.5 times more likely to have a low HDL cholesterol (P < 0.05), while women with a VAT > or =163 cm(2) are 5.5 times more likely to have a low HDL cholesterol (P < 0.01) and approximately 4.0 times more likely to have a high LDL/HDL ratio (P < 0.05) compared with women with a VAT < or =105 cm(2). Women with a VAT > or =163 cm(2) are at a higher risk of having impaired glucose tolerance (P < 0.01).
Conclusions: A VAT > or =106 cm(2) is associated with an elevated risk, and a VAT > or =163 cm(2) with an even greater risk, for these metabolic CHD risk factors compared with women with a VAT < or =105 cm(2). These values may prove useful for defining "visceral obesity" and for identifying women most likely to benefit from preventative interventions.
Assessing alternative strategies for measuring metabolic risk.
Enichen E, Heydari K, Kvedar J NPJ Digit Med. 2024; 7(1):360.
PMID: 39695259 PMC: 11655554. DOI: 10.1038/s41746-024-01376-2.
Itani L, El Ghoch M Nutrients. 2024; 16(22).
PMID: 39599624 PMC: 11597241. DOI: 10.3390/nu16223838.
Uno K, Sato K, Watanabe A, Kudo T, Fukushima N, Takahashi K Surg Today. 2024; 55(3):434-441.
PMID: 39174785 DOI: 10.1007/s00595-024-02925-8.
The Association between Sarcopenic Obesity and DXA-Derived Visceral Adipose Tissue (VAT) in Adults.
De Lorenzo A, Itani L, El Ghoch M, Frank G, De Santis G, Gualtieri P Nutrients. 2024; 16(11).
PMID: 38892578 PMC: 11174391. DOI: 10.3390/nu16111645.
Radecka A, Lubkowska A Diagnostics (Basel). 2023; 13(9).
PMID: 37174967 PMC: 10178172. DOI: 10.3390/diagnostics13091576.